Pharma Stocks
-
Does Royalty Pharma’s (RPRX) Index Upgrade Signal Deeper Defensive Strength In Its Business Model?
Royalty Pharma plc (NasdaqGS:RPRX) was recently added to both the Russell 1000 Defensive Index and the Russell 1000 Value-Defensive Index,…
Read More » -
5 Best Low-Priced Pharma Stocks to Buy Right Now
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off…
Read More » -
Nuvectis Pharma Up 97%, Insider Buyers Are Up 344%
Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders who bought shares over the past year were rewarded handsomely last week. The stock rose…
Read More » -
Moderna Stock and Healthcare Names Facing the Biggest Regulatory Calls
Healthcare regulation is back in focus, and sudden shifts in approvals, safety reviews, and policy debates are putting a spotlight…
Read More » -
Johnson & Johnson (JNJ) Stock After 71% One-Year Rally And Pharma Pipeline Focus
If you are wondering whether Johnson & Johnson stock still offers value after a strong run, this article breaks down…
Read More » -
Where are these stocks headed? – Tata Technologies, Aurobindo Pharma, ACC, Electronics Mart India Limited (EMIL)
I have bought Tata Technologies shares at ₹1,030. What is the technical outlook for this stock? Gunashekar P, Chennai Tata…
Read More » -
Shionogi (TSE:4507) Infectious Disease Progress Keeps Valuation Questions In Play
Why Shionogi stock is back on infectious disease investors’ radar Shionogi (TSE:4507) has drawn fresh attention after Japan approved a…
Read More » -
Trading of Beximco Pharma GDRs resumes on London Stock Exchange
Beximco Pharmaceuticals had its GDRs suspended from trading on 2 January after failing to publish its audited financial statements. TBS…
Read More » -
Why Eli Lilly Stock Jumped to a New All-Time High Today
Shares of Eli Lilly (LLY +7.51%) climbed to a record high on Friday, following several promising developments for the medicine…
Read More » -
Why Acadia Pharmaceuticals Stock Is Soaring Today
Key Points Acadia Pharmaceuticals focuses on underserved rare diseases. Although they’re (by definition) small markets, there’s often little to no…
Read More »